Early experience of percutaneous paravalvular leak closure using a novel Occlutech occluder
Paravalvular regurgitation is an important complication of mitral valve replacement. Although surgical repair is mostly recommended, it is associated with ...
Occlutech obtains Japanese MHW Approval for its ASD Closure Device
Schaffhausen, Switzerland – Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained ...
Occlutech obtains European CE Approval for its novel mVSD Device
Schaffhausen, Switzerland – Occlutech, a leading innovator of implants to treat structural heart disease today announced that it has obtained ...
Occlutech launches ASD and PFO occluders in South Korea
Jena, Germany – Occlutech, a leading European innovator of products to treat structural heart disease today announced that it is ...
Occlutech wins Invalidation of St Jude Patent
Occlutech, a leading European developer of minimally invasive implants for therapy in structural heart disease, today announced that it has ...
Occlutech PLD
I ́m excited to share with you the very first success stories using the Occlutech PLD Occluder for paravalvular leak ...
Occlutech wins Swedish Appeal Court Ruling against AGA St Jude Medical
Occlutech International AB, a leading European developer of minimally invasive implants for the treatment of structural heart disease, today announced ...
Occlutech Group Acquires NonWoTecc Medical GmbH
Schaffhausen, Switzerland January 12, 2013 – Occlutech Holding AG today announced it has successfully completed the all-share acquisition of NonWoTecc ...
Occlutech wins the 2012 Excellence in Medtech Award
The European Tech Tour Association, an independant, not-for-profit organization committed to the development of emerging technology companies from Europe, announced ...
Occlutech wins patent ruling against St Jude-AGA Medical in Italy
Occlutech, a leading European developer of septum occluders such as PFO and ASD devices as well as other innovative, minimally ...